🇺🇸 FDA
Patent

US 10251955

Heparin-mimicking sulfonated reverse thermal gel for the delivery of heparin-binding therapeutic proteins

granted A61KA61K38/385A61K47/32

Quick answer

US patent 10251955 (Heparin-mimicking sulfonated reverse thermal gel for the delivery of heparin-binding therapeutic proteins) held by The Regents of the University of Colorado, a Body Corporate expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/385, A61K47/32, A61K47/34, A61K9/0024